Eiger BioPharmaceuticalsEIGR 
$8.506.25%24h
6.25%24h
Global rank31986
Market cap$12.58M
Change 7d6.25%
YTD Performance23.19%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Eiger BioPharmaceuticals (EIGR)
As of November 2024, Eiger BioPharmaceuticals has a market cap of $12.58M. This makes Eiger BioPharmaceuticals the world's 31986th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Eiger BioPharmaceuticals from 2014 to 2024
-
Value:-
Market cap history of Eiger BioPharmaceuticals from 2014 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $8.43M | -15.56% |
| 2023 | $9.99M | -80.93% |
| 2022 | $52.37M | -77.26% |
| 2021 | $230.36M | -57.77% |
| 2020 | $545.49M | -17.52% |
| 2019 | $661.33M | 46.65% |
| 2018 | $450.95M | -27.17% |
| 2017 | $619.17M | 19.74% |
| 2016 | $517.08M | -47.17% |
| 2015 | $978.68M | -92.47% |
| 2014 | $13.00B | - |
EIGR Market Cap Today is $12.58M 6.25% - 16 Nov 2024
View largest stocks by market cap 
